» Articles » PMID: 29165392

The Tale of Asbestos in Sweden 1972-1986-The Pathway to a Near-Total Ban

Overview
Publisher MDPI
Date 2017 Nov 23
PMID 29165392
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

This paper provides a narrative of the national intervention strategy in Sweden aimed to restrict the industrial use of asbestos. For many years, asbestos was imported for widespread industrial use, resulting in large amounts throughout Swedish society. In 1972, the whistle was blown in a Communist Party parliamentary motion describing asbestos as a health hazard and requesting action to prohibit its use. Although the motion was rejected, it initiated the extensive charting of asbestos sources on a tripartite basis, involving government agencies, and employer and trade-union organizations. Restrictive asbestos management practices were enforced from July 1982. The year 1985 saw the Government Asbestos Commission review, covering use-determining factors, international regulations, and assessments of cancer risks. The relative risks of chrysotile and amphibole were considered internationally (by the IARC), since chrysotile (a Canadian export) was regarded as unharmful in Canada at that time. Prohibiting asbestos use resulted in its virtual disappearance as an import to Sweden from the early 1980s. However, asbestos has undergone a transition from an occupational to a public-health hazard (although some work-related hazards, such as handling and disposal, remain). The transition reflects the public's exposure to existing stocks, in homes, workplaces, etc. Mesothelioma incidence has come to be regarded as an indicator of prevention effectiveness.

Citing Articles

Asbestos and disease - a public health success story?.

Jarvholm B, Burdorf A Scand J Work Environ Health. 2024; 50(2):53-60.

PMID: 38323897 PMC: 10924740. DOI: 10.5271/sjweh.4146.


Four Immune-Related Genes (FN1, UGCG, CHPF2 and THBS2) as Potential Diagnostic and Prognostic Biomarkers for Carbon Nanotube-Induced Mesothelioma.

Xie D, Hu J, Wu T, Cao K, Luo X Int J Gen Med. 2021; 14:4987-5003.

PMID: 34511983 PMC: 8412823. DOI: 10.2147/IJGM.S324365.

References
1.
Wagner J, SLEGGS C, Marchand P . Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960; 17:260-71. PMC: 1038078. DOI: 10.1136/oem.17.4.260. View

2.
RINGERTZ N . [Pneumoconiosis and pulmonary tuberculosis as a background to lung cancer]. Lakartidningen. 1968; 65(11):1099-107. View

3.
Berman D, Crump K . A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 2008; 38 Suppl 1:49-73. DOI: 10.1080/10408440802273156. View

4.
Jarvholm B, Burdorf A . Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden. Scand J Public Health. 2015; 43(8):875-81. PMC: 4638313. DOI: 10.1177/1403494815596500. View

5.
DOLL R . Mortality from lung cancer in asbestos workers. Br J Ind Med. 1955; 12(2):81-6. PMC: 1037613. DOI: 10.1136/oem.12.2.81. View